The Clinical Islet Transplantation (CIT) Consortium is a network of clinical centers and a data coordinating center established in 2004 to conduct studies of islet transplantation in patients
with type 1 diabetes.
Studies conducted by the CIT Consortium will focus on improving the safety and long-term success of methods for transplanting islets, the insulin-producing cells of the pancreas, in people whose own islets have been destroyed by the autoimmune process that characterizes type 1 diabetes.
The network includes the following centers...
University of Miami
Miami, Florida |
University of Minnesota
Minneapolis, Minnesota |
University of Pennsylvania
Philadelphia, Pennsylvania |
Emory University
Atlanta, Georgia |
Northwestern University
Chicago, Illinois |
University of Alberta
Edmonton, Alberta, Canada |
University of California
San Francisco, California |
University of Illinois at Chicago
Chicago, Illinois |
University of Wisconsin
Madison Wisconsin |
Uppsala University
Uppsala, Sweden |
University Hospital Rikshospitalet
Oslo, Norway |
Karolinska University
Stockholm, Sweden |
Massachusetts General Hospital
Boston, Massachusetts |
|
|